$26.69
4.44% yesterday
Nasdaq, Jun 12, 10:16 pm CET
ISIN
US92337F1075
Symbol
VCYT
Sector
Industry

Veracyte Inc Stock price

$26.69
-4.07 13.23% 1M
-17.71 39.89% 6M
-12.91 32.60% YTD
+4.62 20.93% 1Y
+2.41 9.93% 5Y
+15.87 146.67% 10Y
+13.44 101.43% 20Y
Nasdaq, Closing price Thu, Jun 12 2025
-1.24 4.44%
ISIN
US92337F1075
Symbol
VCYT
Sector
Industry

Key metrics

Market capitalization $2.09b
Enterprise Value $1.80b
P/E (TTM) P/E ratio 63.55
EV/FCF (TTM) EV/FCF 22.98
EV/Sales (TTM) EV/Sales 3.89
P/S ratio (TTM) P/S ratio 4.51
P/B ratio (TTM) P/B ratio 1.75
Revenue growth (TTM) Revenue growth 23.42%
Revenue (TTM) Revenue $463.39m
EBIT (operating result TTM) EBIT $26.64m
Free Cash Flow (TTM) Free Cash Flow $78.45m
Cash position $287.36m
EPS (TTM) EPS $0.42
P/E forward 50.77
P/S forward 4.25
EV/Sales forward 3.66
Short interest 7.79%
Show more

Is Veracyte Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Veracyte Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Veracyte Inc forecast:

10x Buy
83%
1x Hold
8%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Veracyte Inc forecast:

Buy
83%
Hold
8%
Sell
8%

Financial data from Veracyte Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
463 463
23% 23%
100%
- Direct Costs 148 148
25% 25%
32%
315 315
22% 22%
68%
- Selling and Administrative Expenses 210 210
12% 12%
45%
- Research and Development Expense 70 70
17% 17%
15%
35 35
220% 220%
8%
- Depreciation and Amortization 8.83 8.83
63% 63%
2%
EBIT (Operating Income) EBIT 27 27
312% 312%
6%
Net Profit 33 33
148% 148%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Veracyte Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Veracyte Inc Stock News

Neutral
Business Wire
16 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance Prostate and Bladder Cancer Research.
Neutral
Business Wire
24 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, announced today it will participate in the following investor conferences. William Blair 45th Annual Growth Stock Conference – Chicago, IL Presentation on June 3rd at 5:40 p.m. Eastern Time Jefferies Global Healthcare Conference – New York, NY Presentation on June 4th at 2:00 p.m. E...
Neutral
Seeking Alpha
about one month ago
Veracyte, Inc. (NASDAQ:VCYT ) Q1 2025 Earnings Call May 7, 2025 4:30 PM ET Company Participants Shayla Gorman - Investor Relations Marc Stapley - Chief Executive Officer Rebecca Chambers - Chief Financial Officer John Leite - Chief Commercial Officer Conference Call Participants Subbu Nambi - Guggenheim Securities Andrew Brackmann - William Blair Puneet Souda - Leerink Partners Colleen Babingto...
More Veracyte Inc News

Company Profile

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Head office United States
CEO Marc Stapley
Employees 824
Founded 2006
Website www.veracyte.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today